Products for Research Use Only
RegisterLogin

NBI-961

CAT: 0804-HY-156437-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-156437-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NBI-961 is a potent NEK2 inhibitor that inhibits proteasomal degradation. NBI-961 induces G2/mitosis arrest and apoptosis in diffuse large B cell lymphoma (DLBCL) cells[1].
CAS Number
2225902-98-5
UNSPSC
12352005
Target
Apoptosis; Mitosis; NEKs; Ser/Thr Protease
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nbi-961.html
Purity
99.73
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C1=C(C=CC=C1)C(F)(F)F)OC2=C(SC(C3=CN=C4C=C(C=CN34)C5=CN(CCN(C)C)N=C5)=C2)C(N)=O
Molecular Formula
C28H27F3N6O2S
Molecular Weight
568.61
References & Citations
[1]Mason McCrury, et al. Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma. Mol Cancer Ther. 2023 Oct 11.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NEK2

Related Products

CatalogName
HY-110135-01NBI-31772
HY-162872NBI-35965
HY-14128NBI-34041
HY-15320-01NBI-74330
HY-135542-01NBI-27914
HY-124879MF 961
HY-14145NBI-75043
HY-107001-01DPC 961
HY-106171NBI-6024
HY-110099-01(±) -NBI-74330

Alternative Products

CatalogName
T81696-01NBI-961
A18347-50NBI-961 (CMP3a) 50mg
A18347-10NBI-961 (CMP3a) 10mg
A18347-1NBI-961 (CMP3a) 1mg
A18347-25NBI-961 (CMP3a) 25mg
A18347-5NBI-961 (CMP3a) 5mg
B7397-1BMS 961
T27203-01DPC-961
BA5292-25NBI-74330
255953(±) -NBI 74330

Popular Products